Child Neurology: Neuromyelitis optica spectrum disorders

Neurology

Volumn 88, Issue 2, 2017, Pages e10-e13

  Bradshaw, Michael J ^a   Vu, Ngochanh ^a   Hunley, Tracy E ^b   Chitnis, Tanuja ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AQUAPORIN 4 ANTIBODY; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB;

ARTICLE; AUTOIMMUNE HEPATITIS; BABINSKI REFLEX; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; DISEASE DURATION; ERYTHROCYTE COUNT; FEMALE; HEPATITIS A; HUMAN; LIVER BIOPSY; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTIC NEURITIS; PLASMA EXCHANGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; VISUAL IMPAIRMENT; NEUROLOGY; PEDIATRICS; PROCEDURES;

CHILD, PRESCHOOL; FEMALE; HUMANS; NEUROLOGY; NEUROMYELITIS OPTICA; PEDIATRICS;

EID: 85009101159     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003495     Document Type: Article

References (10)

1. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189.
2. Weerasinghe D, Lueck C. Mimics and chameleons of optic neuritis. Pract Neurol 2016;16:96-110.
3. Chitnis T, Ness J, Krupp L, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology 2016;86:245-252.
4. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93-100.
5. Romanelli RG, Fassio F, Cappelli F, et al. Autoimmune hepatitis in a patient affected by neuromyelitis optica: a new association. Clin Res Hepatol Gastroenterol 2014; 38:e33-e35.
6. Sand IK. Neuromyelitis optica spectrum disorders. Continuum 2016;22:864-896.
7. Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm 2016;3:e231.
8. Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler 2016;22:185-192.
9. Kleiter I, Gahlen A, Borisow N, et al. Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 2016;79:206-216.
10. Nosadini M, Alper G, Riney CJ, et al. Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 2016;3:e188. doi: 10. 1212/NXI. 0000000000000188.